These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24080662)

  • 1. Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010.
    Banerjee R; Robicsek A; Kuskowski MA; Porter S; Johnston BD; Sokurenko E; Tchesnokova V; Price LB; Johnson JR
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6385-8. PubMed ID: 24080662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012.
    Olesen B; Frimodt-Møller J; Leihof RF; Struve C; Johnston B; Hansen DS; Scheutz F; Krogfelt KA; Kuskowski MA; Clabots C; Johnson JR
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6886-95. PubMed ID: 25199783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.
    Price LB; Johnson JR; Aziz M; Clabots C; Johnston B; Tchesnokova V; Nordstrom L; Billig M; Chattopadhyay S; Stegger M; Andersen PS; Pearson T; Riddell K; Rogers P; Scholes D; Kahl B; Keim P; Sokurenko EV
    mBio; 2013 Dec; 4(6):e00377-13. PubMed ID: 24345742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.
    Hojabri Z; Mirmohammadkhani M; Kamali F; Ghassemi K; Taghavipour S; Pajand O
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1859-1866. PubMed ID: 28550370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of virulence determinants among Escherichia coli ST131 and its H30/H30-Rx subclones in Turkey.
    Er DK; Dündar D; Uzuner H
    Acta Microbiol Immunol Hung; 2023 Mar; 70(1):47-51. PubMed ID: 36459132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli.
    Can F; Kurt-Azap Ö; İspir P; Nurtop E; Seref C; Loçlar İ; Aktaş ON; Orhan YC; Ergonul O
    J Glob Antimicrob Resist; 2016 Mar; 4():49-52. PubMed ID: 27436393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage.
    Peirano G; van der Bij AK; Freeman JL; Poirel L; Nordmann P; Costello M; Tchesnokova VL; Pitout JD
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3762-7. PubMed ID: 24752265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and Functional Portrait of a Highly Virulent, CTX-M-15-Producing H30-Rx Subclone of Escherichia coli Sequence Type 131.
    Ranjan A; Shaik S; Hussain A; Nandanwar N; Semmler T; Jadhav S; Wieler LH; Ahmed N
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6087-95. PubMed ID: 26195517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.
    Drawz SM; Porter S; Kuskowski MA; Johnston B; Clabots C; Kline S; Ferrieri P; Johnson JR
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5331-9. PubMed ID: 26100703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of Escherichia coli sequence type 131 among antimicrobial-resistant E. coli isolates from geriatric patients.
    Ho PL; Chu YP; Lo WU; Chow KH; Law PY; Tse CW; Ng TK; Cheng VC; Que TL
    J Med Microbiol; 2015 Mar; 64(Pt 3):243-247. PubMed ID: 25587081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131.
    Banerjee R; Johnson JR
    Antimicrob Agents Chemother; 2014 Sep; 58(9):4997-5004. PubMed ID: 24867985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of bloodstream-associated
    Can F; Kurt-Azap O; Nurtop E; Ispir P; Seref C; Ergonul O
    J Med Microbiol; 2016 Apr; 65(4):306-310. PubMed ID: 26795934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Quinolone Resistance of Extended-Spectrum β-Lactamase-Producing
    Teramae M; Osawa K; Shigemura K; Kitagawa K; Shirakawa T; Fujisawa M; Miyara T
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.
    Johnson JR; Urban C; Weissman SJ; Jorgensen JH; Lewis JS; Hansen G; Edelstein PH; Robicsek A; Cleary T; Adachi J; Paterson D; Quinn J; Hanson ND; Johnston BD; Clabots C; Kuskowski MA;
    Antimicrob Agents Chemother; 2012 May; 56(5):2364-70. PubMed ID: 22354301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.
    Sherchan JB; Hayakawa K; Miyoshi-Akiyama T; Ohmagari N; Kirikae T; Nagamatsu M; Tojo M; Ohara H; Sherchand JB; Tandukar S
    Antimicrob Agents Chemother; 2015; 59(6):3424-32. PubMed ID: 25824221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and characteristics of Escherichia coli sequence type 131 and its H30 and H30Rx subclones: a multicenter study from Korea.
    Kim SY; Park YJ; Johnson JR; Yu JK; Kim YK; Kim YS
    Diagn Microbiol Infect Dis; 2016 Feb; 84(2):97-101. PubMed ID: 26643062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: comparison with H30 and H30-Rx subclones of O25b:H4-ST131.
    Dahbi G; Mora A; Mamani R; López C; Alonso MP; Marzoa J; Blanco M; Herrera A; Viso S; García-Garrote F; Tchesnokova V; Billig M; de la Cruz F; de Toro M; González-López JJ; Prats G; Chaves F; Martínez-Martínez L; López-Cerezo L; Denamur E; Blanco J
    Int J Med Microbiol; 2014 Nov; 304(8):1247-57. PubMed ID: 25455219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraintestinal pathogenic Escherichia coli sequence type 131 H30-R and H30-Rx subclones in retail chicken meat, Italy.
    Ghodousi A; Bonura C; Di Carlo P; van Leeuwen WB; Mammina C
    Int J Food Microbiol; 2016 Jul; 228():10-3. PubMed ID: 27082892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant.
    Demirci-Duarte S; Unalan-Altintop T; Eser OK; Cakar A; Altun B; Sancak B; Gur D
    Diagn Microbiol Infect Dis; 2020 Sep; 98(1):115098. PubMed ID: 32603974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends of extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 and its H30 subclone in a French hospital over a 15-year period.
    Sauget M; Cholley P; Vannier A; Thouverez M; Nicolas-Chanoine MH; Hocquet D; Bertrand X
    Int J Antimicrob Agents; 2016 Dec; 48(6):744-747. PubMed ID: 27836379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.